{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:10:11Z","timestamp":1779347411050,"version":"3.51.4"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/aaco3727","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:50:56Z","timestamp":1764924656000},"page":"8896-8906","source":"Crossref","is-referenced-by-count":0,"title":["TNXB modulates radiosensitivity of esophageal cancer through the ATM\/P53 pathway"],"prefix":"10.62347","volume":"17","author":[{"given":"Huiying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"102","DOI":"10.21037\/atm-20-2798","article-title":"Trends in conditional overall survival of esophageal cancer: a population-based study","volume":"9","author":"Deng","year":"2021","unstructured":"Deng W, Yu R, Yang Z, Dong X and Wang W. Trends in conditional overall survival of esophageal cancer: a population-based study. Ann Transl Med 2021; 9: 102.","journal-title":"Ann Transl Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"831283","DOI":"10.3389\/fnut.2022.831283","article-title":"Prognostic value of geriatric nutritional risk index in esophageal carcinoma: a systematic review and meta-analysis","volume":"9","author":"Zhou","year":"2022","unstructured":"Zhou J, Fang P, Li X, Luan S, Xiao X, Gu Y, Shang Q, Zhang H, Yang Y, Zeng X and Yuan Y. Prognostic value of geriatric nutritional risk index in esophageal carcinoma: a systematic review and meta-analysis. Front Nutr 2022; 9: 831283.","journal-title":"Front Nutr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/cbr.2020.3643","article-title":"Synergism between immunotherapy and radiotherapy in esophageal cancer: an overview of current knowledge and future perspectives","volume":"36","author":"Sardaro","year":"2021","unstructured":"Sardaro A, Ferrari C, Carbonara R, Altini C, Lavelli V and Rubini G. Synergism between immunotherapy and radiotherapy in esophageal cancer: an overview of current knowledge and future perspectives. Cancer Biother Radiopharm 2021; 36: 123-132.","journal-title":"Cancer Biother Radiopharm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15330338211048051","DOI":"10.1177\/15330338211048051","article-title":"Additional radiotherapy with or without chemotherapy following endoscopic resection for stage I esophageal carcinoma: a pilot study","volume":"20","author":"Yang","year":"2021","unstructured":"Yang X, Men Y, Wang J, Kang J, Sun X, Zhao M, Sun S, Yuan M, Bao Y, Ma Z, Wang G and Hui Z. Additional radiotherapy with or without chemotherapy following endoscopic resection for stage I esophageal carcinoma: a pilot study. Technol Cancer Res Treat 2021; 20: 15330338211048051.","journal-title":"Technol Cancer Res Treat"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21147\/j.issn.1000-9604.2021.01.06","article-title":"Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: a phase ii clinical trial","volume":"33","author":"Yang","year":"2021","unstructured":"Yang X, Zhai Y, Bi N, Zhang T, Deng L, Wang W, Wang X, Chen D, Zhou Z, Wang L and Liang J. Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: a phase ii clinical trial. Chin J Cancer Res 2021; 33: 53-60.","journal-title":"Chin J Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"887525","DOI":"10.3389\/fonc.2022.887525","article-title":"Efficacy and safety of radiotherapy\/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: a systematic review and meta-analysis","volume":"12","author":"Wu","year":"2022","unstructured":"Wu J, Deng R, Ni T, Zhong Q, Tang F, Li Y and Zhang Y. Efficacy and safety of radiotherapy\/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: a systematic review and meta-analysis. Front Oncol 2022; 12: 887525.","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"16495","DOI":"10.1038\/s41598-024-67419-6","article-title":"Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy","volume":"14","author":"Kong","year":"2024","unstructured":"Kong Y, Su M, Fang J, Chen M, Zheng C, Jiang Y, Tao K, Wang C, Qiu G, Ji Y, Wang Y and Yang Y. Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy. Sci Rep 2024; 14: 16495.","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1107787","DOI":"10.3389\/fgene.2023.1107787","article-title":"Tenascin-X as a causal gene for classical-like ehlers-danlos syndrome","volume":"14","author":"Okuda-Ashitaka","year":"2023","unstructured":"Okuda-Ashitaka E and Matsumoto KI. Tenascin-X as a causal gene for classical-like ehlers-danlos syndrome. Front Genet 2023; 14: 1107787.","journal-title":"Front Genet"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Marino R, Garrido NP, Ramirez P, Notaristefano G, Moresco A, Touzon MS, Vaiani E, Finkielstain G, Obregon MG, Balbi V, Soria I and Belgorosky A. Ehlers-danlos syndrome: molecular and clinical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia. J Clin Endocrinol Metab 2021; 106: e2789-e2802.","DOI":"10.1210\/clinem\/dgab033"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41597-024-03536-1","article-title":"Machine learning-enhanced extraction of biomarkers for high-grade serous ovarian cancer from proteomics data","volume":"11","author":"De Silva","year":"2024","unstructured":"De Silva S, Alli-Shaik A and Gunaratne J. Machine learning-enhanced extraction of biomarkers for high-grade serous ovarian cancer from proteomics data. Sci Data 2024; 11: 685.","journal-title":"Sci Data"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41421-022-00479-y","article-title":"Integrated proteogenomic characterization of medullary thyroid carcinoma","volume":"8","author":"Shi","year":"2022","unstructured":"Shi X, Sun Y, Shen C, Zhang Y, Shi R, Zhang F, Liao T, Lv G, Zhu Z, Jiao L, Li P, Xu T, Qu N, Huang N, Hu J, Zhang T, Gu Y, Qin G, Guan H, Pu W, Li Y, Geng X, Zhang Y, Chen T, Huang S, Zhang Z, Ge S, Wang W, Xu W, Yu P, Lu Z, Wang Y, Guo L, Wang Y, Guo T, Ji Q and Wei W. Integrated proteogenomic characterization of medullary thyroid carcinoma. Cell Discov 2022; 8: 120.","journal-title":"Cell Discov"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/1878-0261.13361","article-title":"Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome","volume":"17","author":"Lu","year":"2023","unstructured":"Lu X, Fu Y, Gu L, Zhang Y, Liao AY, Wang T, Jia B, Zhou D and Liao L. Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. Mol Oncol 2023; 17: 261-283.","journal-title":"Mol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1449668","DOI":"10.3389\/fendo.2024.1449668","article-title":"Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a mendelian randomization study and colocalization analysis","volume":"15","author":"Song","year":"2024","unstructured":"Song J and Yang H. Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a mendelian randomization study and colocalization analysis. Front Endocrinol (Lausanne) 2024; 15: 1449668.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/mc.23166","article-title":"A functional variant in TNXB promoter associates with the risk of esophageal squamous-cell carcinoma","volume":"59","author":"Yang","year":"2020","unstructured":"Yang N, Tian J, Wang X, Mei S, Zou D, Peng X, Zhu Y, Yang Y, Gong Y, Ke J, Zhong R, Chang J and Miao X. A functional variant in TNXB promoter associates with the risk of esophageal squamous-cell carcinoma. Mol Carcinog 2020; 59: 439-446.","journal-title":"Mol Carcinog"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/or.2024.8724","article-title":"Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)","volume":"51","author":"Zhang","year":"2024","unstructured":"Zhang W, Zhu M, Xiang Y, Sun Y, Li S, Cai J and Zeng H. Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review). Oncol Rep 2024; 51: 65.","journal-title":"Oncol Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.21873\/anticanres.13156","article-title":"Tenascin XB is a novel diagnostic marker for malignant mesothelioma","volume":"39","author":"Nakayama","year":"2019","unstructured":"Nakayama K, Seike M, Noro R, Takeuchi S, Matsuda K, Kunugi S, Kubota K and Gemma A. Tenascin XB is a novel diagnostic marker for malignant mesothelioma. Anticancer Res 2019; 39: 627-633.","journal-title":"Anticancer Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","unstructured":"An L, Li M and Jia Q. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer 2023; 22: 140.","journal-title":"Mol Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/cancers16030658","article-title":"A meta-analysis and review of radiation dose escalation in definitive radiation therapy between squamous cell carcinoma and adenocarcinoma of esophageal cancer","volume":"16","author":"Liou","year":"2024","unstructured":"Liou Y, Lan TL and Lan CC. A meta-analysis and review of radiation dose escalation in definitive radiation therapy between squamous cell carcinoma and adenocarcinoma of esophageal cancer. Cancers (Basel) 2024; 16: 658.","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/ATVBAHA.123.321067","article-title":"Loss of smooth muscle tenascin-X inhibits vascular remodeling through increased TGF-beta signaling","volume":"44","author":"Liang","year":"2024","unstructured":"Liang G, Lv XF, Huang W, Jin YJ, Roquid KA, Kawase H and Offermanns S. Loss of smooth muscle tenascin-X inhibits vascular remodeling through increased TGF-beta signaling. Arterioscler Thromb Vasc Biol 2024; 44: 1748-1763.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/CIRCRESAHA.121.320694","article-title":"Tenascin-X mediates flow-induced suppression of EndMT and atherosclerosis","volume":"130","author":"Liang","year":"2022","unstructured":"Liang G, Wang S, Shao J, Jin YJ, Xu L, Yan Y, Gunther S, Wang L and Offermanns S. Tenascin-X mediates flow-induced suppression of EndMT and atherosclerosis. Circ Res 2022; 130: 1647-1659.","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2220\/biomedres.45.67","article-title":"Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis","volume":"45","author":"Matsumoto","year":"2024","unstructured":"Matsumoto KI, Higuchi T, Umeki M, Ono M and Sakamoto S. Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis. Biomed Res 2024; 45: 67-76.","journal-title":"Biomed Res"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Howes AC, Perisic O and Williams RL. Structural insights into the activation of ataxia-telangiectasia mutated by oxidative stress. Sci Adv 2023; 9: eadi8291.","DOI":"10.1126\/sciadv.adi8291"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4103\/1673-5374.350194","article-title":"Ataxia-telangiectasia mutated plays an important role in cerebellar integrity and functionality","volume":"18","author":"Mitiagin","year":"2023","unstructured":"Mitiagin Y and Barzilai A. Ataxia-telangiectasia mutated plays an important role in cerebellar integrity and functionality. Neural Regen Res 2023; 18: 497-502.","journal-title":"Neural Regen Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1940-6207.CAPR-20-0448","article-title":"Germline pathogenic variants in the ataxia telangiectasia mutated (ATM) gene are associated with high and moderate risks for multiple cancers","volume":"14","author":"Hall","year":"2021","unstructured":"Hall MJ, Bernhisel R, Hughes E, Larson K, Rosenthal ET, Singh NA, Lancaster JM and Kurian AW. Germline pathogenic variants in the ataxia telangiectasia mutated (ATM) gene are associated with high and moderate risks for multiple cancers. Cancer Prev Res (Phila) 2021; 14: 433-440.","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.3390\/cancers13215498","article-title":"ATM kinase dead: from ataxia telangiectasia syndrome to cancer","volume":"13","author":"Putti","year":"2021","unstructured":"Putti S, Giovinazzo A, Merolle M, Falchetti ML and Pellegrini M. ATM kinase dead: from ataxia telangiectasia syndrome to cancer. Cancers (Basel) 2021; 13: 5498.","journal-title":"Cancers (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.biocel.2022.106230","article-title":"Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer","volume":"147","author":"Gulliver","year":"2022","unstructured":"Gulliver C, Hoffmann R and Baillie GS. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer. Int J Biochem Cell Biol 2022; 147: 106230.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"720194","DOI":"10.3389\/fcell.2021.720194","article-title":"A novel mechanism of ataxia telangiectasia mutated mediated regulation of chromatin remodeling in hypoxic conditions","volume":"9","author":"Likhatcheva","year":"2021","unstructured":"Likhatcheva M, Gieling RG, Brown JAL, Demonacos C and Williams KJ. A novel mechanism of ataxia telangiectasia mutated mediated regulation of chromatin remodeling in hypoxic conditions. Front Cell Dev Biol 2021; 9: 720194.","journal-title":"Front Cell Dev Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023048720","article-title":"TPP1 inhibits DNA damage response and chemosensitivity in esophageal cancer","volume":"33","author":"Wen","year":"2023","unstructured":"Wen J, Zhong X, Gao C, Yang M, Tang M, Yuan Z, Wang Q, Xu L, Ma Q, Guo X and Fang L. TPP1 inhibits DNA damage response and chemosensitivity in esophageal cancer. Crit Rev Eukaryot Gene Expr 2023; 33: 77-91.","journal-title":"Crit Rev Eukaryot Gene Expr"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0161407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:35:09Z","timestamp":1779345309000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0161407.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/aaco3727","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}